Skip to main content

IDEXX Laboratories, Inc.

corporate_fare Company Profile

IDEXX Laboratories, Inc.

IDXX·NASDAQ·Life Sciences·CIK 0000874716

IDEXX Laboratories, Inc. develops, manufactures, and distributes products and provides services primarily for the companion animal veterinary, livestock, poultry and dairy, and water testing industries. The company also manufactures and sells human medical point-of-care diagnostic products. Its primary products and services include point-of-care veterinary diagnostic products, such as instruments, consumables, and rapid assay test kits; veterinary reference laboratory diagnostic and consulting services; practice management systems, software, and diagnostic imaging systems and services for veterinarians; health monitoring, biological materials testing, laboratory diagnostic instruments, and services for the biomedical research community; diagnostic and health-monitoring products for livestock, poultry, and dairy; and products that test water for certain microbiological contaminants. The company operates primarily through three reportable business segments: Companion Animal Group, Water quality products, and Livestock, Poultry and Dairy. Its Other operating segment combines human medical diagnostic products with out-licensing arrangements. The Companion Animal Group (CAG) segment provides diagnostic and information management products and services for the companion animal veterinary industry, including point-of-care diagnostic solutions, outside reference laboratory services, and veterinary software and services. CAG Diagnostics offers diagnostic capabilities through various modalities, including point-of-care diagnostic solutions and outside reference laboratory services. Its point-of-care diagnostic solutions include the IDEXX VetLab suite of point-of-care chemistry, hematology, immunoassay, electrolyte, urinalysis, cytology/morphology, blood gas, and coagulation analyzers, along with associated consumable products.

IDEXX Laboratories, Inc. (NASDAQ:IDXX) is a publicly traded company in the Life Sciences sector. Wiseek has independently scored 18 items for IDXX at importance 7 or higher on its 1–10 market-impact scale. Its most recent item scored 7 or higher is dated 2026-11-02, rated 7/10. Across its 18 most recent items scored 7 or higher, the top rating is 8/10, with 10 rated 8 or above. Recent SEC coverage for IDXX spans 10-Q, 8-K, DEFA14A, DEF 14A.

Recent high-impact activity:

  • IDEXX 10-Q Details Q3 EPS of $4.01, $934M Nine-Month Net Income and $250M CoVetAI Deal
  • IDEXX Lifts Full-Year Outlook as Diagnostics Demand Offsets 1.8% Drop in Vet Visits; Shares Jump 19%
  • IDEXX Beats on Q3 Revenue, Raises Full-Year EPS Outlook to $14.96-$15.16
  • IDEXX Posts $4.01 Third-Quarter EPS
  • IDEXX Acquires CoVetAI to Boost Veterinary Workflow Intelligence

Financial Snapshot

Fiscal year ended December 31, 2025
Revenue
$4.3B
Net Income
$1.06B
Diluted EPS
$13.08
Op. Cash Flow
$1.18B
Free Cash Flow
$1.06B
Gross Profit
$2.66B
Operating Income
$1.36B
Cash & Equivalents
$180.07M
Total Debt
$449.84M
Debt / Equity
0.28×
Net Margin
24.6%
Shares Outstanding
79.71M sh
Source: 10-K · filed 2026-02-20 · accession 0000874716-26-000038

Short Interest & Short Volume

4.45 days to cover

FINRA reported short interest of 2,354,117 shares in IDXX as of the October 30, 2026 settlement, a 22.0% increase from the prior period — about 4.5 days to cover at its recent average daily volume. On November 20, 2026, 50.2% of IDXX volume reported to FINRA trade-reporting facilities was marked short.

Short interest (bi-monthly positions)2,354,117 shares as of October 30, 2026
Change vs prior period▲ 22.0%
Days to cover4.45 at avg daily volume of 529,434
Daily short volume (FINRA facilities)50.2% of 164,006 shares on November 20, 2026
5-day average short volume54.4%

Daily short sale volume covers trades reported to FINRA trade-reporting facilities and is not the same as short interest (bi-monthly reported positions). Source: FINRA — FINRA is the owner and source of this short interest and short sale volume data; it may not be redistributed.

Browse all tickers starting with I →
$674.72 -0.22% today
52-week range · as of 2026-11-02 $500.61 – $769.98
Market cap
$53.28B
Volume
614.4K (1.0× avg)
3-mo avg 634.8K
Live data · 2026-11-22 07:12 UTC · Market closed

show_chartPrice Chart

Loading chart...

feed IDXX - Latest Insights

IDXX
Nov 02, 2026, 4:29 PM EST
Filing Type: 10-Q
Importance Score:
7
Price at Filing: $670.00
Real-time Price: $674.72 info
Change: +$4.72 (+0.70%) info
Market Cap: $53.276B info
IDXX
Nov 02, 2026, 11:45 AM EST
Source: Reuters
Importance Score:
8
Price at Filing: $659.20
Real-time Price: $674.72 info
Change: +$15.53 (+2%) info
Market Cap: $53.276B info
IDXX
Nov 02, 2026, 6:45 AM EST
Source: Reuters
Importance Score:
7
Price at Filing: $555.00
Real-time Price: $674.72 info
Change: +$119.72 (+22%) info
Market Cap: $53.276B info
IDXX
Nov 02, 2026, 6:30 AM EST
Source: Dow Jones Newswires
Importance Score:
7
Price at Filing: $544.00
Real-time Price: $674.72 info
Change: +$130.72 (+24%) info
Market Cap: $53.276B info
IDXX
Sep 16, 2026, 7:00 AM EDT
Source: Dow Jones Newswires
Importance Score:
7
Price at Filing: $505.26
Real-time Price: $674.72 info
Change: +$169.46 (+34%) info
Market Cap: $53.276B info
IDXX
Aug 04, 2026, 4:16 PM EDT
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $588.09
Real-time Price: $674.72 info
Change: +$86.63 (+15%) info
Market Cap: $53.276B info
IDXX
Aug 04, 2026, 6:32 AM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $597.90
Real-time Price: $674.72 info
Change: +$76.82 (+13%) info
Market Cap: $53.276B info
IDXX
Aug 04, 2026, 6:32 AM EDT
Source: Dow Jones Newswires
Importance Score:
8
Price at Filing: $588.78
Real-time Price: $674.72 info
Change: +$85.94 (+15%) info
Market Cap: $53.276B info
IDXX
May 15, 2026, 4:00 PM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $528.79
Real-time Price: $674.72 info
Change: +$145.93 (+28%) info
Market Cap: $53.276B info
IDXX
May 05, 2026, 4:14 PM EDT
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $562.97
Real-time Price: $674.72 info
Change: +$111.76 (+20%) info
Market Cap: $53.276B info
IDXX
May 05, 2026, 6:31 AM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $558.00
Real-time Price: $674.72 info
Change: +$116.72 (+21%) info
Market Cap: $53.276B info
IDXX
May 05, 2026, 6:30 AM EDT
Source: Reuters
Importance Score:
8
Price at Filing: $558.00
Real-time Price: $674.72 info
Change: +$116.72 (+21%) info
Market Cap: $53.276B info
IDXX
Mar 27, 2026, 4:00 PM EDT
Filing Type: DEFA14A
Importance Score:
7
Price at Filing: $558.32
Real-time Price: $674.72 info
Change: +$116.40 (+21%) info
Market Cap: $53.276B info
IDXX
Mar 27, 2026, 4:00 PM EDT
Filing Type: DEF 14A
Importance Score:
7
Price at Filing: $558.32
Real-time Price: $674.72 info
Change: +$116.40 (+21%) info
Market Cap: $53.276B info
IDXX
Mar 13, 2026, 4:00 PM EDT
Filing Type: PRE 14A
Importance Score:
7
Price at Filing: $573.82
Real-time Price: $674.72 info
Change: +$100.90 (+18%) info
Market Cap: $53.276B info
IDXX
Feb 20, 2026, 4:09 PM EST
Filing Type: 10-K
Importance Score:
8
Price at Filing: $635.66
Real-time Price: $674.72 info
Change: +$39.06 (+6%) info
Market Cap: $53.276B info
IDXX
Feb 02, 2026, 6:39 AM EST
Filing Type: 8-K
Importance Score:
8
Price at Filing: $690.00
Real-time Price: $674.72 info
Change: -$15.28 (-2%) info
Market Cap: $53.276B info
IDXX
Jan 13, 2026, 8:33 AM EST
Filing Type: 8-K
Importance Score:
7
Price at Filing: $714.04
Real-time Price: $674.72 info
Change: -$39.32 (-6%) info
Market Cap: $53.276B info
Research tools: Filing Impact Index Dilution Tracker Split Calendar Open Datasets